The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Metcalf Brian W since year 2005.
The trader's CIK number is 1234564.
At the time of this reporting, Metcalf Brian W is the Chief Drug Discovery of Incyte Corp .
(stock ticker symbol incy).
See this page for all insider trading activities at Incyte Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2011-04-11||INCY||Incyte Corp||Option Ex||100,000||5.46||546,000|
|2011-03-16||INCY||Incyte Corp||Option Ex||50,000||8.52||425,750|
|2011-03-18||INCY||Incyte Corp||Option Ex||160,000||9.79||1,565,920|
|2011-02-17||INCY||Incyte Corp||Option Ex||50,000||5.97||298,500|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Metcalf Brian W (Chief Drug Discovery of Incyte Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.